New era for blood transfusions through genome sequencing

May 18, 2018, Brigham and Women's Hospital
blood
Credit: Wikimedia Commons

Most people are familiar with A, B, AB and O blood types, but there are hundreds of additional blood group "antigens" on red blood cells—substances that can trigger the body's immune response—that differ from person to person. Each year, up to 16 deaths reported to the Federal Drug Administration are attributed to mismatches in red blood cell antigens that are not related to differences in A, B and O blood groups. Currently, no method is available that can determine all blood antigens. But as whole genome sequencing becomes routine for patients, it may be possible to modernize therapy by identifying both rare donors and at-risk recipients before blood transfusions. In a new study, investigators from Brigham and Women's Hospital and Harvard Medical School, as well as from the New York Blood Center have leveraged the MedSeq Project - the first randomized trial of whole genome sequencing in healthy adults—to develop and validate a computer program that can comprehensively and cost-effectively determine differences in individuals' blood types with more than 99 percent accuracy. The team's results are reported in The Lancet Haematology.

"Blood complications are common in patients needing chronic transfusion, but with current technology it is not cost effective to do typing for all antigens," said first author William Lane, MD, Ph.D., director of Clinical Laboratory Informatics and assistant director of the Tissue Typing Laboratory in the BWH Department of Pathology. "But the algorithm we have developed can be applied to type everyone for all relevant blood groups at a low cost once sequencing is obtained."

Blood transfusions are one of the most common procedures in medicine with more than 11 million units of blood transfused in the U.S. each year. Complications from blood transfusions can be life-threatening. When the body encounters foreign antigens on the donor cells, it can stimulate production of antibodies that can destroy the transfused donor cells. From birth, people have antibodies unique to their ABO blood type, but other antibodies against specific blood antigens can be stimulated during pregnancy from exposure to fetal cells or exposure to donor cells when receiving multiple blood transfusions.

"This approach has the potential to be one of the first routine clinical uses of genomics for medical care for patients needing blood transfusion," said co-first author Connie M. Westhoff, Ph.D., at the New York Blood Center. "It could prevent serious or even fatal complications because once patients are sensitized they have a life-long risk of hemolytic transfusion reactions if is needed in an emergency."

Today, most testing for blood donors and patients include only ABO and Rh matching, but more than 300 antigens and 33 platelet antigens are known. To create a way to cost-effectively type many people for these antigens, Lane teamed up with scientists directing the MedSeq Project and experts in blood group genetics at the New York Blood Center to build a database and develop a computer software algorithm, known as bloodTyper, that could rapidly and accurately predict an individual's blood group antigen profile from genomic sequences. Lane, Westhoff and colleagues validated the software by comparing it to traditional, and more labor-intensive, methods. bloodTyper was more than 99 percent accurate when typing from the MedSeq Project participants' genomes. Lane notes that this work would not have been possible without access to samples from the MedSeq Project, and close collaboration with MedSeq's principal investigator, Robert Green, MD, MPH, and co-investigator, Heidi Rehm, Ph.D.

"This report demonstrates a previously unanticipated use case and benefit that will accrue as whole genome sequencing become a routine part of medical care," said Green, one of the senior authors on the study, director of the Genomes2People Research Program at BWH and professor of medicine at Harvard Medical School. "Genome sequencing can now identify potential transfusion recipients who need rare blood types and the individuals who can safely provide them."

Explore further: Tailoring blood cells in the laboratory

More information: William J Lane et al, Automated typing of red blood cell and platelet antigens: a whole-genome sequencing study, The Lancet Haematology (2018). DOI: 10.1016/S2352-3026(18)30053-X

Related Stories

Tailoring blood cells in the laboratory

April 26, 2018
For some blood transfusion patients, it is particularly difficult to find a compatible blood donor. Growing matching blood cells in the laboratory has long been an overarching goal of scientists for these patients. Research ...

FDA OKs test to improve blood donor-recipient matching

May 22, 2014
(HealthDay)—The first gene-based test to help determine red blood cell compatibility between a blood donor and a recipient has been approved by the U.S. Food and Drug Administration.

Risks associated with receipt of blood transfusion from previously pregnant donor

October 17, 2017
Among patients who received red blood cell transfusions, receiving a transfusion from a donor who was ever pregnant, compared with a male donor, was associated with an increased risk of death among male recipients of transfusions ...

How 1000 new genetic variants were discovered in blood groups

January 26, 2017
1000 new mutations in the blood group genes—that is what physician and former programmer Mattias Möller found in his research study in which he developed new software and investigated blood group genes in 2,504 people. ...

Transfusion outcomes differ by race for peds scoliosis surgery

April 2, 2018
(HealthDay)—In the surgical correction of pediatric scoliosis, black race is independently associated with increased estimated blood loss, increased rate of blood transfusion, and increased amount of blood transfused, according ...

Test strip able to identify blood type in less than a minute

March 16, 2017
(Medical Xpress)—A team of researchers at Third Military Medical University in China has developed a test strip that can be used to identify a person's blood type in less than a minute. In their paper published in the journal ...

Recommended for you

Research shows it's possible to reverse damage caused by aging cells

August 15, 2018
What's the secret to aging well? University of Minnesota Medical School researchers have answered it- on a cellular level.

This matrix delivers healing stem cells to injured elderly muscles

August 15, 2018
A car accident leaves an aging patient with severe muscle injuries that won't heal. Treatment with muscle stem cells from a donor might restore damaged tissue, but doctors are unable to deliver them effectively. A new method ...

Male tobacco smokers have brain-wide reduction of CB1 receptors

August 15, 2018
Chronic, frequent tobacco smokers have a decreased number of cannabinoid CB1 receptors, the "pot receptor", when compared with non-smokers, reports a study in Biological Psychiatry.

Byproducts of 'junk DNA' implicated in cancer spread

August 14, 2018
The more scientists explore so-called "junk" DNA, the less the label seems to fit.

Doctors may be able to enlist a mysterious enzyme to stop internal bleeding

August 14, 2018
Blood platelets are like the sand bags of the body. Got a cut? Platelets pile in to clog the hole and stop the bleeding.

Artificial placenta created in the laboratory

August 14, 2018
In order to better understand important biological membranes, it is necessary to explore new methods. Researchers at Vienna University of Technology (Vienna) have succeeded in creating an artificial placental barrier on a ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.